Environment and systemic lupus erythematosus: An overview

References

• Mok CC, Lau CS. Pathogenesis of systemic lupus erythematosus. J Clin Pathol 2003; 56: 481–490
   PubMed Web of Science ®Google Scholar
• Sherer Y, Gorstein A, Fritzler MJ, Shoenfeld Y. Autoantibody explosion in systemic lupus erythematosus: More than 100 different antibodies found in SLE patients. Semin Arthritis Rheum 2004; 34: 501–537
   PubMed Web of Science ®Google Scholar
• Rahman A. Autoantibodies, lupus and the science of sabotage. Rheumatology (Oxford) 2004; 43: 1326–1336
   PubMed Web of Science ®Google Scholar
• Deapen D, Escalante A, Weinrib L. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum 1992; 35: 311–318
   PubMed Web of Science ®Google Scholar
• Järvinen P, Kaprio J, Makitalo R. Systemic lupus erythematosus and related systemic diseases in a nationwide twin cohort: An increased prevalence of disease in MZ twins and concordance of disease features. J Intern Med 1992; 31: 67–72
   Google Scholar
• Cooper GS, Miller FW, Pandey JP. The role of genetic factors in autoimmune disease: Implications for environmental research. Environ Health Perspect 1999; 107(Suppl 5)693–700
   PubMedGoogle Scholar
• Edwards CJ. Environmental factors and lupus: Are we looking too late?. Lupus 2005; 14: 423–425
   PubMedGoogle Scholar
• Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, Harley JB. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003; 349: 1526–1533
   PubMed Web of Science ®Google Scholar
• Baxter AG, Horsfall AC, Healey D, et al. Mycobacteria precipitate an SLE-like syndrome in diabetes-prone NOD mice. Immunology 1994; 83: 227–231
   PubMed Web of Science ®Google Scholar
• Zandman-Goddard G, Shoenfeld Y. Infections and SLE. Autoimmunity 2005; 38: 473–485
   PubMed Web of Science ®Google Scholar
• Petri M. Infection in systemic lupus erythematosus. Rheum Dis Clin North Am 1998; 24: 423–456
   PubMed Web of Science ®Google Scholar
• Zandman-Goddard G, Shoenfeld Y. SLE and infections. Clin Rev Allergy Immunol 2003; 25: 29–40
   PubMed Web of Science ®Google Scholar
• Fessler BJ. Infectious diseases in systemic lupus erythematosus: Risk factors, management and prophylaxis. Best Pract Res Clin Rheumatol 2002; 16: 281–291
   PubMed Web of Science ®Google Scholar
• Bouza E, Moya JG, Munoz P. Infections in systemic lupus erythematosus and rheumatoid arthritis. Infect Dis Clin North Am 2001; 15: 335–361
   PubMed Web of Science ®Google Scholar
• McClain MT, Heinlen LD, Dennis GJ, Roebuck J, Harley JB, James JA. Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat Med 2005; 11: 85–89
   PubMed Web of Science ®Google Scholar
• Kaufman KM, Kirby MY, Harley JB, James JA. Peptide mimics of a major lupus epitope of SmB/B’. Ann NY Acad Sci 2003; 987: 215–229
   PubMedGoogle Scholar
• Moon UY, Park SJ, Oh ST, Kim WU, Park SH, Lee SH, Cho CS, Kim HY, Lee WK, Lee SK. Patients with systemic lupus erythematosus have abnormally elevated Epstein-Barr virus load in blood. Arthritis Res Ther 2004; 6: R295–R302
   PubMed Web of Science ®Google Scholar
• McClain MT, Harley JB, James JA. The role of Epstein-Barr virus in systemic lupus erythematosus. Front Biosci 2001; 6: E137–E147
   PubMedGoogle Scholar
• Hsu TC, Tsay GJ. Human parvovirus B19 infection in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2001; 40: 152–157
   PubMed Web of Science ®Google Scholar
• Sekigawa I, Nawata M, Seta N, et al. Cytomegalovirus infection in patients with systemic lupus erythematosus. Clin Exp Rheumatol 2002; 20: 559–564
   PubMed Web of Science ®Google Scholar
• Parks C, Cooper GS. Occupational exposures and risk of Systemic Lupus Erythematosus. Autoimmunity 2005; 38: 497–506
   PubMed Web of Science ®Google Scholar
• American Thoracic Society. Adverse effects of crystalline silica exposure. Am J Resp Crit Care Med 1997; 155: 761–768
   PubMed Web of Science ®Google Scholar
• Koeger AC, Lang T, Alcaix D. Silica-associated connective tissue disease. A study of 24 cases. Medicine (Baltimore) 1995; 74: 221–237
   PubMed Web of Science ®Google Scholar
• Bramwell B. Diffuse scleroderma: Its frequency and occurrence in stonemasons; its treatment by fibrinolysisin: Elevations of temperature due to fibrinolysin injections. Edinburg Med J 1914; 12: 387
   Google Scholar
• Miall WE, Caplan A, Cochrane AL. An epidemiological study of rheumatoid arthritis associated with characteristic chest X-ray appearances in coal-workers. Br Med J 1958; II: 1231–1236
   Google Scholar
• Parks CG, Conrad K, Cooper GS. Occupational exposure to crystalline silica and autoimmune disease. Environ Health Perspect 1999; 107(Suppl 5)793–802
   PubMed Web of Science ®Google Scholar
• Cooper GS, Parks CG. Occupational and environmental exposures as risk factors for systemic lupus erythematosus. Curr Rheumatol Rep 2004; 6: 367–374
   PubMedGoogle Scholar
• Cooper GS, Miller FW, Germolec DR. Occupational exposures and autoimmune diseases. Int Immunopharmacol 2002; 2: 303–313
   PubMed Web of Science ®Google Scholar
• Sanchez-Roman J, Wichmann I, Salaberri J. Multiple clinical and biological autoimmune manifestation in 50 workers after occupational exposure to silica. Ann Rheum Dis 1993; 52: 534–538
   PubMed Web of Science ®Google Scholar
• Conrad K, Mehlhorn J, Luthke K. Systemic lupus erythematosus after heavy exposure to quartz dust in uranium mines: Clinical and serological characteristics. Lupus 1996; 5: 62–69
   PubMed Web of Science ®Google Scholar
• Rosenman KD, Moore-Fuller M, Reilly MJ. Connective tissue disease and silicosis. Am J Ind Med 1999; 35: 375–381
   PubMed Web of Science ®Google Scholar
• Parks CG, Cooper GS, Nylander-French LA. Occupational exposure to crystalline silica and risk of systemic lupus erythematosus: A population-based, case-control study in the southeastern United States. Arthritis Rheum 2002; 46: 1840–1850
   PubMed Web of Science ®Google Scholar
• Parks CG, Cooper GS, Nylander-French LA. Assessing exposure to crystalline silica from farm work: A population-based study in the southeastern United States. Ann Epidemiol 2003; 13: 385–392
   PubMed Web of Science ®Google Scholar
• Parks CG, Cooper GS, Nylander-French LA. Comparing questionnaire-based methods to assess occupational silica exposure. Epidemiology 2004; 15: 433–441
   PubMedGoogle Scholar
• Brown JM, Archer AJ, Pfau JC, Holian A. Silica accelerated systemic autoimmune disease in lupus-prone New Zealand mixed mice. Clin Exp Immunol 2003; 131: 415–421
   PubMed Web of Science ®Google Scholar
• Pfau JC, Brown JM, Holian A. Silica-exposed mice generate autoantibodies to apoptotic cells. Toxicology 2004; 195: 167–176
   PubMed Web of Science ®Google Scholar
• Huang SH, Hubbs AF, Stanley CF. Immunoglobulin responses to experimental silicosis. Toxicol Sci 2001; 59: 108–117
   PubMed Web of Science ®Google Scholar
• Mohr C, Gemsa D, Graebner C. Systemic macrophage stimulation in rats with silicosis: Enhanced release of tumor necrosis factor-alpha from alveolar and peritoneal macrophages. Am J Respir Cell Mol Biol 1991; 5: 395–402
   PubMed Web of Science ®Google Scholar
• Bruckner JV, Warren DA. Toxic effects of solvents and vapors. Casarett and Doull's Toxicology: The basic science of poisons. McGraw Hill, New York 2001; 869–916
   Google Scholar
• Aryal BK, Khuder SA, Schaub EA. Meta-analysis of systemic sclerosis and exposure to solvents. Am J Ind Med 2001; 40: 271–274
   PubMed Web of Science ®Google Scholar
• Cooper GS, Parks CG, Treadwell EL, St Clair EW, Gilkeson GS, Dooley MA. Occupational risk factors for the development of systemic lupus erythematosus. J Rheumatol 2004; 31: 1928–1933
   PubMed Web of Science ®Google Scholar
• Khan MF, Kaphalia BS, Prabhakar BS. Trichloroethene-induced autoimmune response in female MRL/mice. Toxicol Appl Pharmacol 1995; 134: 155–160
   PubMed Web of Science ®Google Scholar
• Griffin JM, Blossom SJ, Jackson SK. Trichloroethylene accelerates an autoimmune response by Th1 T cell activation in MRL/mice. Immunopharmacology 2000; 46: 123–137
   PubMed Web of Science ®Google Scholar
• Griffin JM, Gilbert KM, Pumford NR. Inhibition of CYP2E1 reverses CD4 T-cell alterations in trichloroethylene-treated MRL/mice. Toxicol Sci 2000; 54: 384–389
   PubMed Web of Science ®Google Scholar
• Gilbert KM, Whitlow AB, Pumford NR. Environmental contaminant and disinfection by-product trichloroacetaldehyde stimulates T cells in vitro. Int Immunopharmacol 2004; 4: 25–36
   PubMed Web of Science ®Google Scholar
• Kilburn KH, Warshaw RH. Prevalence of symptoms of systemic lupus erythematosus (SLE) and of fluorescent antinuclear antibodies associated with chronic exposure to trichloroethylene and other chemicals in well water. Environ Res 1992; 57: 1–9
   PubMed Web of Science ®Google Scholar
• Kardestuncer T, Frumkin H. Systemic lupus erythematosus in relation to environmental pollution: An investigation in an African–American community in North Georgia. Arch Environ Health 1997; 52: 85–90
   PubMed Web of Science ®Google Scholar
• Holsapple MP. Autoimmunity by pesticides: A critical review of the state of the science. Toxicol Lett 2002; 127: 101–109
   PubMed Web of Science ®Google Scholar
• Balluz L, Philen R, Ortega L. Investigation of systemic lupus erythematosus in Nogales, Arizona. Am J Epidemiol 2001; 154: 1029–1036
   PubMed Web of Science ®Google Scholar
• Colborn T, vom Saal FS, Soto AM. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ Health Perspect 1993; 101: 378–384
   PubMed Web of Science ®Google Scholar
• Freni-Titulaer LW, Kelley DB, Grow AG. Connective tissue disease in southeastern Georgia: A case-control study of etiologic factors. Am J Epidemiol 1989; 130: 404–409
   PubMed Web of Science ®Google Scholar
• Rosenberg AM, Semchuck KM, McDuffie HH, et al. Prevalence of antinuclear antibodies in a rural population. J Toxicol Environ Health A 1999; 57: 225–236
   PubMed Web of Science ®Google Scholar
• Sanchez-Guerrero J, Karlson EW, Colditz GA. Hair dye use and the risk of developing systemic lupus erythematosus. Arthritis Rheum 1996; 39: 657–662
   PubMed Web of Science ®Google Scholar
• Hardy CJ, Palmer BP, Muir KR, Powell RJ. Systemic lupus erythematosus (SLE) and hair treatment: A large community based case-control study. Lupus 1999; 8: 541–544
   PubMed Web of Science ®Google Scholar
• Cooper GS, Dooley MA, Treadwell EL. Smoking and use of hair treatments in relation to risk of developing systemic lupus erythematosus. J Rheumatol 2001; 12: 2653–2656
   Google Scholar
• Petri M, Allbritton J. Hair product use in systemic lupus erythematosus. A case-control study. Arthritis Rheum 1992; 35: 625–629
   PubMed Web of Science ®Google Scholar
• Jimenez-Alonso J, Sabio JM, Perez-Alvarez F, et al. Hair dye treatment use and clinical course in patients with systemic lupus erythematosus and cutaneous lupus. Lupus 2002; 11: 430–434
   PubMedGoogle Scholar
• Reidenberg MM, Drayer DE, Lorenzo B. Acetylation phenotypes and environmental chemical exposure of people with idiopathic systemic lupus erythematosus. Arthritis Rheum. 1993; 36: 971–973
   PubMed Web of Science ®Google Scholar
• Sarzi-Puttini P, Atzeni F, Capsoni F, Lubrano E, Doria A. Drug-induced lupus erythematosus. Autoimmunity 2005; 38: 507–518
   PubMed Web of Science ®Google Scholar
• Hess E. Drug-related lupus. N Engl J Med 1988; 318: 1460–1462
   PubMed Web of Science ®Google Scholar
• Yung RL, ChB MB, Richardson BC. Drug-induced lupus. Rheum Dis Clin North Am 1994; 20: 61–86
   PubMed Web of Science ®Google Scholar
• Burlingame RW, Rubin RL. Drug-induced anti-histone autoantibodies display two patterns of reactivity with substructures of chromatin. J Clin Invest 1991; 88: 680–690
   PubMed Web of Science ®Google Scholar
• Rubin RL, Waga S. Antihistone antibodies in systemic lupus erythematosus. J Rheumatol 1987; 13: 118–126
   Google Scholar
• Atzeni F, Marrazza MG, Sarzi-Puttini P, Carrabba M. Drug-induced lupus erythematosus. Reumatismo 2003; 55: 147–154
   PubMedGoogle Scholar
• Weinstein A. Drug-induced systemic lupus erythematosus. Prog Clin Immunol 1980; 4: 1–21
   PubMedGoogle Scholar
• Ahmed SA, Hissong BD, Verthelyi D, et al. Gender and risk of autoimmune diseases: Possible role of estrogenic compounds. Environ Health Perspect 1999; 107(Suppl 5)681–686
   PubMed Web of Science ®Google Scholar
• Marselos M, Tomatis L. Diethylstilboestrol II: Pharmacology, toxicology and carcinogenicity in experimental animals. Eur J Cancer 1993; 29A: 149–155
   Web of Science ®Google Scholar
• Noller KL, Blair PB, O'Brien PC, et al. Increased occurrence of autoimmune disease among women exposed in utero to diethylstilbestrol. Fertil Steril 1988; 49: 1080–1082
   PubMed Web of Science ®Google Scholar
• Meier CR, Sturkenboom MC, Cohen AS, Jick H. Postmenopausal estrogen replacement therapy and the risk of developing systemic lupus erythematosus or discoid lupus. J Rheumatol 1998; 25: 1515–1519
   PubMed Web of Science ®Google Scholar
• Arden NK, Lloyd ME, Spector TD, Hughes GR. Safety of hormone replacement therapy (HRT) in systemic lupus erythematosus (SLE). Lupus 1994; 3: 11–13
   PubMed Web of Science ®Google Scholar
• Kreidstein S, Urowitz MB, Gladman DD, Gough J. Hormone replacement therapy in systemic lupus erythematosus. J Rheumatol 1997; 24: 2149–2152
   PubMed Web of Science ®Google Scholar
• Buyon JP, Petri MA, Kim MY, et al. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: A randomized trial. Ann Intern Med 2005; 142: 953–962
   PubMed Web of Science ®Google Scholar
• Cooper GS, Treadwell EL, Dooley MA. N-acetyl transferase genotypes in relation to risk of developing systemic lupus erythematosus. J Rheumatol 2004; 31: 76–80
   PubMed Web of Science ®Google Scholar
• Costenbader KH, Karlson EW. Cigarette smoking and systemic lupus erythematosus: A smoking gun?. Autoimmunity 2005; 38: 541–547
   PubMed Web of Science ®Google Scholar
• Costenbader KH, Kim DJ, Peerzada J. Cigarette smoking and the risk of systemic lupus erythematosus: A meta-analysis. Arthritis Rheum 2004; 50: 849–857
   PubMed Web of Science ®Google Scholar
• Sopori M. Effects of cigarette smoke on the immune system. Nat Rev Immunol 2002; 2: 372–377
   PubMed Web of Science ®Google Scholar
• Toloza SM, Uribe AG, McGwin G, Jr, et al. LUMINA Study Group. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events. Arthritis Rheum 2004; 50: 3947–3957
   PubMed Web of Science ®Google Scholar
• Minami Y, Sasaki T, Arai Y, Kurisu Y, Hisamichi S. Diet and systemic lupus erythematosus: A 4 year prospective study of Japanese patients. J Rheumatol 2003; 30: 747–754
   PubMedGoogle Scholar
• Bae SC, Kim SJ, Sung MK. Impaired antioxidant status and decreased dietary intake of antioxidants in patients with systemic lupus erythematosus. Rheumatol Int 2002; 22: 238–243
   PubMed Web of Science ®Google Scholar
• Reifen R, Blank M, Afek A, et al. Dietary polyunsaturated fatty acids decrease anti-dsDNA and anti-cardiolipin antibodies production in idiotype induced mouse model of systemic lupus erythematosus. Lupus 1998; 7: 192–197
   PubMed Web of Science ®Google Scholar
• Walton AJ, Snaith ML, Locniskar M, et al. Dietary fish oil and the severity of symptoms in patients with systemic lupus erythematosus. Ann Rheum Dis 1991; 50: 463–466
   PubMed Web of Science ®Google Scholar
• Tam LS, Li EK, Leung VY, et al. Effects of vitamins C and E on oxidative stress markers and endothelial function in patients with systemic lupus erythematosus: A double blind, placebo controlled pilot study. J Rheumatol 2005; 32: 275–282
   PubMed Web of Science ®Google Scholar
• Leung LH. Systemic lupus erythematosus: A combined deficiency disease. Med Hypotheses 2004; 62: 922–924
   PubMedGoogle Scholar
• Minami Y, Sasaki T, Arai Y, Kurisu Y, Hisamichi S. Diet and systemic lupus erythematosus: A 4 year prospective study of Japanese patients. J Rheumatol 2003; 30: 747–754
   PubMedGoogle Scholar
• Prete PE. The mechanism of action of l-canavanine in inducing autoimmune phenomena. Arthritis Rheum 1985; 28: 1198–1200
   PubMed Web of Science ®Google Scholar
• Kuhn A, Beissert S. Photosensitivity in Lupus Erythematosus. Autoimmunity 2005; 38: 519–529
   PubMed Web of Science ®Google Scholar
• Albrecht J, Berlin JA, Bravermann IM, et al. Dermatology position paper on the revision of the 1982 ACR criteria for systemic lupus erythematosus. Lupus 2004; 13: 839–849
   PubMedGoogle Scholar
• Doria A, Biasinutto C, Ghirardello A, et al. Photosensitivity in systemic lupus erythematosus: Laboratory testing of ARA/ACR definition. Lupus 1996; 5: 263–268
   PubMed Web of Science ®Google Scholar
• Kuhn A, Lehmann P. Photosensitivity in lupus erythematosus. Cutaneous lupus erythematosus1st Ed., A Kuhn, P Lehmann, T Ruzicka. Springer, Heidelberg 2004; 161–175
   Google Scholar
• Norris DA. Pathomechanisms of photosensitive lupus erythematosus. J Invest Dermatol 1993; 100: 58S–68S
   PubMed Web of Science ®Google Scholar
• Vila LM, Mayor AM, Valentin AH, et al. Association of sunlight exposure and photoprotection measures with clinical outcome in systemic lupus erythematosus. R Health Sci J 1999; 18: 89–94
   PubMedGoogle Scholar
• Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994; 179: 1317–1330
   PubMed Web of Science ®Google Scholar
• Casciola-Rosen LA, Rosen A. Ultraviolet light-induced keratinocyte apoptosis: A potential mechanism for the induction of skin lesions and autoantibody production in LE. Lupus 1997; 6: 175–180
   PubMed Web of Science ®Google Scholar
• Hess EV, Farhey Y. Etiology, environmental relationships, epidemiology, and genetics of systemic lupus erythematosus. Curr Opin Rheumatol 1995; 7: 371–375
   PubMedGoogle Scholar
• Ioannou Y, Isenberg DA. Current concepts for the management of systemic lupus erythematosus in adults: A therapeutic challenge. Postgrad Med J 2002; 78: 599–606
   PubMedGoogle Scholar